Abstract
To explore the functional consequences of cannabinoid withdrawal in the rat mesolimbic dopamine system, we investigated the anatomical morphology of the mesencephalic, presumed dopaminergic, neurons and their main post-synaptic target in the Nucleus Accumbens. We found that TH-positive neurons shrink and Golgi-stained medium spiny neurons loose dendritic spines in withdrawal rats after chronic cannabinoids administration. Similar results were observed after administration of the cannabinoid antagonist rimonabant to drug-naive rats supporting a role for endocannabinoids in neurogenesis, axonal growth and synaptogenesis. This evidence supports the tenet that withdrawal from addictive compounds alters functioning of the mesolimbic system. The data add to a growing body of work which indicates a hypodopaminergic state as a distinctive feature of the “addicted brain”.
Keywords: Cannabinoids, dopamine, nucleus accumbens, withdrawal, cannabis derivatives, cannabinoid CB1 receptors, neuro- biological effects, psychological functions, dopamine (DA), Ventral Tegmental area (VTA), cannabinoid dependence
Current Neuropharmacology
Title: Altered Mesolimbic Dopamine System in THC Dependence
Volume: 9 Issue: 1
Author(s): S. Spiga, A. Lintas and M. Diana
Affiliation:
Keywords: Cannabinoids, dopamine, nucleus accumbens, withdrawal, cannabis derivatives, cannabinoid CB1 receptors, neuro- biological effects, psychological functions, dopamine (DA), Ventral Tegmental area (VTA), cannabinoid dependence
Abstract: To explore the functional consequences of cannabinoid withdrawal in the rat mesolimbic dopamine system, we investigated the anatomical morphology of the mesencephalic, presumed dopaminergic, neurons and their main post-synaptic target in the Nucleus Accumbens. We found that TH-positive neurons shrink and Golgi-stained medium spiny neurons loose dendritic spines in withdrawal rats after chronic cannabinoids administration. Similar results were observed after administration of the cannabinoid antagonist rimonabant to drug-naive rats supporting a role for endocannabinoids in neurogenesis, axonal growth and synaptogenesis. This evidence supports the tenet that withdrawal from addictive compounds alters functioning of the mesolimbic system. The data add to a growing body of work which indicates a hypodopaminergic state as a distinctive feature of the “addicted brain”.
Export Options
About this article
Cite this article as:
Spiga S., Lintas A. and Diana M., Altered Mesolimbic Dopamine System in THC Dependence, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017083
DOI https://dx.doi.org/10.2174/157015911795017083 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
A Novel Combined Pharmacophore Mapping and Quantitative Structure Selectivity Relationship Analysis for the Development of Potent and Selective Human Aldose Reductase Inhibitors
Current Computer-Aided Drug Design Pharmacological and Cellular Therapies to Prevent Restenosis after Percutaneous Transluminal Angioplasty and Stenting
Cardiovascular & Hematological Agents in Medicinal Chemistry Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry An Update in the Management of Obesity: The Weight of CNS Targets
Recent Patents on CNS Drug Discovery (Discontinued) The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence
Current Pharmaceutical Design The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents
Current Topics in Medicinal Chemistry The Role of LH in Ovarian Stimulation
Current Pharmaceutical Biotechnology Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Current Pharmaceutical Design Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets Prevention of Sexually Transmitted Human Immunodeficiency Virus (HIV) Infection in Adolescents
Current HIV Research Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery Skin Tests in the Diagnosis of Drug Hypersensitivity Reactions
Current Pharmaceutical Design Potential Applications for Using Stem Cells in Spine Surgery
Current Stem Cell Research & Therapy Skeletal Effects of Systemic and Topical Corticosteroids
Current Drug Safety Progress in the Development of Melanocortin Receptor Selective Ligands
Current Pharmaceutical Design Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases
Coronaviruses A Review of Intrahepatic Cholestasis of Pregnancy
Current Women`s Health Reviews Identifying the Predictors of Self-Management Behaviors in Patients with Diabetes Based on Ecological Approach: A Systematic Review
Current Diabetes Reviews